Amgen sees no bone safety concerns around experimental obesity drug-March 2024-www.financetom.com

Amgen sees no bone safety concerns around experimental obesity drug

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Amgen sees no bone safety concerns around experimental obesity drug

Nov 13, 2024 11:28 AM

(Reuters) - Amgen ( AMGN ) said on Wednesday it does not see any bone safety concerns around the use of its experimental obesity drug, a day after data from an early-stage study dragged its stock 7% lower.

(Reporting by Leroy Leo in Bengaluru; Editing by Shinjini Ganguli)

Previous page： Update: CEMATRIX Up 3.1% as Boosts Credit Facility to $8 Million Next page： Update: Sierra Metals Begins Trading on the Lima Stock Exchange

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Update: CEMATRIX Up 3.1% as Boosts Credit Facility to $8 Million

Jun 28, 2024

11:41 AM EDT, 06/28/2024 (MT Newswires) -- CEMATRIX ( CTXXF ) , a cellular concrete product manufacturer, on Thursday said it increased its credit facility with the Canadian Imperial Bank of Commerce to $8 million, up from the previous limit of $3 million. The other terms of the credit facility, which has yet be drawn upon, remain materially unchanged. The...

Update: Sierra Metals Begins Trading on the Lima Stock Exchange

Jun 28, 2024

11:43 AM EDT, 06/28/2024 (MT Newswires) -- Sierra Metals ( SMTSF ) said Friday its shares are now trading on the Lima Stock Exchange under the BVL:SMT symbol. The Lima Stock Exchange is a regional integration of stock exchanges that brings together the Chilean, Colombian and Peruvian markets, according to Sierra. We are pleased to list our common shares on...

Pyxis Tankers Closes Dry Bulk Vessel Acquisition Through Joint Venture

Jun 28, 2024

11:42 AM EDT, 06/28/2024 (MT Newswires) -- Pyxis Tankers ( PXS ) said Friday it has completed the acquisition of a dry bulk vessel through a joint venture with an entity related to its chairman and chief executive officer. The company said it invested $7.3 million in cash and will issue 267,857 restricted common shares for a 60% ownership interest...

Why Is Cancer Vaccine Developer Elicio Therapeutics Stock Trading Lower On Friday?

Jun 28, 2024

Thursday, Elicio Therapeutics Inc ( ELTX ) released new preliminary data from the ongoing AMPLIFY-7P Phase 1a study of its off-the-shelf investigational therapeutic cancer vaccine candidate, ELI-002 7P. The preliminary data showed patients receiving ELI-002 7P at the Phase 2 dose of 4.9mg AMP-peptide were yet to reach the median disease-free survival (DFS) endpoint as of the May 24, 2024...